According to a new report, published by KBV research, The Global C-Reactive Protein Testing Market size is expected to reach $3.5 billion by 2030, rising at a market growth of 2.8% CAGR during the forecast period.
The Inflammatory Bowel Disease segment is showcasing a CAGR of 3.1% during (2023 - 2030). Inflammatory bowel disease can be identified through the use of elevated CRP levels. CRP levels tend to increase when the gastrointestinal tract is inflamed due to diseases like Crohn's disease or ulcerative colitis.
The Immunoturbidimetric Assays segment is leading the Global C-reactive Protein Testing Market by Assay Type in 2022; thereby, achieving a market value of $1.5 billion by 2030. The development and accessibility of affordable automated immunoturbidimetric assays that provide high sensitivity to evaluate a broad range of CRP levels are anticipated to boost the segment's growth. Clinical biochemistry routinely analyzes CRP and high-sensitivity CRP, which indicate systemic inflammation and atherosclerosis risk.
The Hospitals & Clinics segment is experiencing a CAGR of 2.9% during (2023 - 2030). These facilities are staffed with veterinarians and veterinary technicians who have specialized training and experience in pain management. They are knowledgeable about the latest techniques and medications for managing pain in animals. Veterinarians in these facilities can assess each animal's pain level and create a tailored pain management plan. This approach ensures that the treatment is appropriate for the specific condition and needs of the pet.
The North America region dominated the Global C-reactive Protein Testing Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1.2 billion by 2030. The Europe region is anticipated to grow at a CAGR of 2.6% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 3.4% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/c-reactive-protein-testing-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Danaher Corporation, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Laboratory Corporation of America Holdings, Randox Laboratories Limited, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Horiba, Ltd., Merck KGaA, and Zoetis, Inc.
By Application
By Assay Type
By End User
By Geography
Companies Profiled
Unique Offerings 
